Top

Gepubliceerd in:

01-05-2014 | Original Paper

A Model of Pediatric Psychopharmacology-Psychotherapy Treatment Integration in the Ambulatory Clinical Setting

Auteurs: Daniel F. Connor, Alok Banga

Gepubliceerd in: Journal of Child and Family Studies | Uitgave 4/2014

Abstract

We describe the rationale for, core elements of, and implementation challenges of an integrated psychopharmacology-psychotherapy treatment model for early-onset behavioral health disorders that commonly present to child and adolescent psychiatrists working in the ambulatory clinical setting. These disorders include Attention Deficit/Hyperactivity Disorder (ADHD) with or without Oppositional Defiant Disorder (ODD), Depression, and Anxiety Disorders Each of these disorders has support for an evidence-based psychotherapy and a psychopharmacological treatment. A description of the model is presented which is potentially transportable into managed care systems and is designed for efficient delivery in a time and resource constrained environment treating children with complex mental health care needs. Potential limitations of the model are discussed.

vorige artikel Reducing Psychotropic Medications in an Intensive Residential Treatment Center

volgende artikel Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools

AACAP. (1997a). Practice parameters for the assessment and treatment of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 85S–121S.CrossRef

AACAP. (1997b). Practice parameters for the psychiatric assessment of children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 31(10 Supplement), 1386–1402.

AACAP. (1998). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 37(10 Supplement), 63S–83S.

AACAP. (2009). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 961–973.CrossRef

Achenbach, T. M., & Dumenci, L. (2001). Advances in empirically based assessment: Revised cross-informant syndromes and new DSM-oriented scales for the CBCL, YSR, and TRF: Comment on Lengua, Sadowksi, Friedrich, and Fischer (2001). Journal of Consulting and Clinical Psychology, 69(4), 699–702.PubMedCrossRef

APA. (2000). Diagnostic and statistical manual of mental disorders-TR (4th ed.). Washington, DC: American Psychiatric Press.

Barkley, R. A. (1997). Defiant children: A clinician’s manual for assessment and parent training (2nd ed.). New York, NY: Guilford Press.

Birmaher, B., Axelson, D. A., Monk, K., Kalas, C., Clark, D. B., Ehmann, M., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 415–423.PubMedCrossRef

Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association, 299(8), 901–913.PubMedCentralPubMedCrossRef

Bridge, J. A., Lyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297(15), 1683–1696.PubMedCrossRef

Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., & Stein, R. E. (2007). Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics, 120(5), e1313–e1326.PubMedCrossRef

Chrisman, A. K., Enderlin, H. T., Landry, K. L., Colvin, J. S., & DeJohn, M. R. (2007). Teaching evidence-based medicine pediatric psychopharmacology: Integrating psychopharmacologic treatment into the broad spectrum of care. Child and Adolescent Psychiatric Clinics of North America, 16(1), 165–181.PubMedCrossRef

Conners, C. K. (2008). Conners rating scales (3rd ed.). North Tonawanda, NY: Multi-Health Systems.

Connolly, S. D., & Bernstein, G. A. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46(2), 267–283.PubMedCrossRef

Connor, D. F., & Fisher, S. G. (1997). An interactional model of child and adolescent mental health clinical case formulation. Clinical Child Psychology and Psychiatry, 2(3), 353–368.CrossRef

Connor, D. F., McLaughlin, T. J., Jeffers-Terry, M., O’Brien, W. H., Stille, C. J., Young, L. M., et al. (2006). Targeted child psychiatric services: A new model of pediatric primary clinician–child psychiatry collaborative care. Clinical Pediatrics (Phila), 45(5), 423–434.CrossRef

Connor, D. F., & Meltzer, B. M. (2006). Pediatric psychopharmacology fast facts. New York: W.W. Norton and Company.

Dilallo, J. J., & Weiss, G. (2009). Motivational interviewing and adolescent psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 48(2), 108–113.PubMedCrossRef

Eisenthal, S., & Lazare, A. (1976). Evaluation of the initial interview in a walk-in clinic. The patient’s perspective on a “customer approach”. Journal of Nervous and Mental Disease, 162(3), 169–176.PubMedCrossRef

El Hage, W., Powell, J. F., & Surguladze, S. A. (2009). Vulnerability to depression: What is the role of stress genes in gene x environment interaction? Psychological Medicine, 39(9), 1407–1411.PubMedCrossRef

Findling, R. L., Connor, D. F., Wigal, T., Eagan, C., & Onofrey, M. N. (2008). A linguistic analysis of in-office dialogue among psychiatrists, parents, and child and adolescent patients with ADHD. Journal of Attention Disorders, 13(1), 78–86.PubMedCrossRef

Freitag, C. M., Rohde, L. A., Lempp, T., & Romanos, M. (2010). Phenotypic and measurement influences on heritability estimates in childhood ADHD. European Child and Adolescent Psychiatry, 19(3), 311–323.PubMedCrossRef

Greenhill, L. L., Pliszka, S., Dulcan, M. K., Bernet, W., Arnold, V., Beitchman, J., et al. (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry, 41(2 Supplement), 26S–49S.PubMed

Guy, W. (1976). Assessment manual for psychopharmacology. Washington, DC: U.S. Department of Health, Education, and Welfare.

Hamilton, J. D. (2006). Evidence-based practice for outpatient clinical teams. Journal of the American Academy of Child and Adolescent Psychiatry, 45(3), 364–370.PubMedCrossRef

Hawley, K. M., & Jensen-Doss, A. (2008). Evidence-based psychological interventions for emotional and behavioral disorders. In M. L. Wolraich, D. D. Drotar, P. H. Dworkin, & E. C. Perrin (Eds.), Developmental-behavioral pediatrics: Evidence and practice (pp. 240–280). Philadelphia: Mosby Elsevier.

Hughes, C. W., Emslie, G. J., Crismon, M. L., Posner, K., Birmaher, B., Ryan, N., et al. (2007). Texas children’s medication algorithm project: Update from Texas consensus conference panel on medication treatment of childhood major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 667–686.PubMedCrossRef

Irby, D. M., & Wilkerson, L. (2008). Teaching when time is limited. British Medical Journal, 336(7640), 384–387.PubMedCentralPubMedCrossRef

Kendall, P. C., Robin, J. A., Hedtke, K. A., Suveg, C., Flannery-Schroeder, E., & Gosch, E. (2005). Considering CBT with anxious youth? Think exposures. Cognitive and Behavioral Practice, 12, 136–150.CrossRef

Kodish, I., Rockhill, C., Ryan, S., & Varley, C. (2011). Pharmacotherapy for anxiety disorders in children and adolescents. Pediatric Clinics of North America, 58(1), 55–72.PubMedCrossRef

Kutcher, S., Davidson, S., & Manion, I. (2009). Child and youth mental health: Integrated health care using contemporary competency-based teams. Paediatrics & Child Health, 14(5), 315–318.

Lambert, M. J. (2010). Prevention and treatment failure: The use of measuring, monitoring, and feedback in clinical practice. Washington, DC: American Psychological Association.CrossRef

Luhrmann, T. M. (2000). Of two minds: The growing disorder in American psychiatry. New York: Random House.

March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., et al. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. Journal of the American Medical Association, 292(7), 807–820.PubMedCrossRef

March, J. S., Szatmari, P., Bukstein, O., Chrisman, A., Kondo, D., Hamilton, J. D., et al. (2007). AACAP 2005 research forum: Speeding the adoption of evidence-based practice in pediatric psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry, 46(9), 1098–1110.PubMedCrossRef

March, J. S., & Vitiello, B. (2009). Clinical messages from the treatment for adolescents with depression study (TADS). American Journal of Psychiatry, 166(10), 1118–1123.PubMedCrossRef

March, J. S., & Wells, K. (2003). Combining pharmacotherapy and psychotherapy: An evidence-based approach. In A. Martin, L. Scahill, D. S. Charney, & J. F. Leckman (Eds.), Pediatric psychopharmacology principles and practice (pp. 426–443). New York: Oxford University Press.

McCarty, C. A., & Weisz, J. R. (2007). Effects of psychotherapy for depression in children and adolescents: What we can (and can’t) learn from meta-analysis and component profiling. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 879–886.PubMedCentralPubMedCrossRef

McClellan, J. M., & Werry, J. S. (2003). Evidence-based treatments in child and adolescent psychiatry: An inventory. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1388–1400.PubMedCrossRef

MTA Group. (1999). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The multimodal treatment study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1088–1096.CrossRef

Murray, L., Creswell, C., & Cooper, P. J. (2009). The development of anxiety disorders in childhood: An integrative review. Psychological Medicine, 39(9), 1413–1423.PubMedCrossRef

Olfson, M., Gameroff, M. J., Marcus, S. C., & Waslick, B. D. (2003). Outpatient treatment of child and adolescent depression in the United States. Archives of General Psychiatry, 60(12), 1236–1242.PubMedCrossRef

Olfson, M., Klerman, G. L., & Pincus, H. A. (1993). The roles of psychiatrists in organized outpatient mental health settings. American Journal of Psychiatry, 150(4), 625–631.PubMed

Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry, 167(12), 1456–1463.PubMedCrossRef

Pliszka, S. R., & Bukstein, O. G. (2007). Managing attention-deficit/hyperactivity disorder. In: American academy of child & adolescent psychiatry (Ed.) (3.0 ed.). Baltimore, MD.: International Guidelines Center for Evidence-Based Practice.

POTS Group. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Journal of the American Medical Association, 292(16), 1969–1976.CrossRef

Ramos-Quiroga, J. A., & Casas, M. (2011). Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder. CNS Drugs, 25(1), 17–36.PubMedCrossRef

Reeves, G., & Anthony, B. (2009). Multimodal treatments versus pharmacotherapy alone in children with psychiatric disorders: Implications of access, effectiveness, and contextual treatment. Paediatric Drugs, 11(3), 165–169.PubMedCrossRef

Riba, M. B., & Balon, R. (2008). Combining psychotherapy and pharmacotherapy. In R. E. Hales, S. C. Yudofsky, & G. O. Gabbard (Eds.), The American psychiatric publishing textbook of psychiatry (5th ed., pp. 1279–1301). Arlington, VA: American Psychiatric Publishing.

RUPP Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344(17), 1279–1285.CrossRef

Rutter, M., Moffitt, T. E., & Caspi, A. (2006). Gene-environment interplay and psychopathology: Multiple varieties but real effects. Journal of Child Psychology and Psychiatry, 47(3–4), 226–261.PubMedCrossRef

Rynn, M. A., Riddle, M. A., Yeung, P. P., & Kunz, N. R. (2007). Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: Two placebo-controlled trials. American Journal of Psychiatry, 164(2), 290–300.PubMedCrossRef

Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158(12), 2008–2014.PubMedCrossRef

Sackett, D. L., Richardson, W., Rosenberg, W., & Haynes, B. (2000). Evidence-based medicine (2nd ed.). London: Churchill Livingstone.

Sander, J. B., & McCarty, C. A. (2005). Youth depression in the family context: Familial risk factors and models of treatment. Clinical Child and Family Psychology Review, 8(3), 203–219.PubMedCentralPubMedCrossRef

Scott, R. W., Mughelli, K., & Deas, D. (2005). An overview of controlled studies of anxiety disorders treatment in children and adolescents. Journal of the National Medical Association, 97(1), 13–24.PubMedCentralPubMed

Shaffer, D., Gould, M. S., Brasic, J., Ambrosini, P., Fisher, P., Bird, H., et al. (1983). A children’s global assessment scale (CGAS). Archives of General Psychiatry, 40(11), 1228–1231.PubMedCrossRef

Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., et al. (2008). Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: Findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. American Journal of Psychiatry, 165(11), 1420–1431.PubMedCrossRef

Steele, M., Jensen, P. S., & Quinn, D. M. (2006). Remission versus response as the goal of therapy in ADHD: A new standard for the field? Clinical Therapeutics, 28(11), 1892–1908.PubMedCrossRef

Trivedi, H. K., Pattison, N. A., & Neto, L. B. (2011). Pediatric medical home: Foundations, challenges, and future directions. Pediatric Clinics of North America, 58(4), 787–801, ix.PubMedCrossRef

Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766.PubMedCentralPubMedCrossRef

Weissman, M. M., Pilowsky, D. J., Wickramaratne, P. J., Talati, A., Wisniewski, S. R., Fava, M., et al. (2006). Remissions in maternal depression and child psychopathology: A STAR*D-child report. Journal of the American Medical Association, 295(12), 1389–1398.PubMedCrossRef

Weisz, J. R., Chorpita, B. F., Palinkas, L. A., Schoenwald, S. K., Miranda, J., Bearman, S. K., et al. (2012). Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: A randomized effectiveness trial. Archives of General Psychiatry, 69(3), 247–282.CrossRef

Weisz, J. R., & Jensen, P. S. (1999). Efficacy and effectiveness of child and adolescent psychotherapy and pharmacotherapy. Mental Health Services Research, 1(3), 125–157.PubMedCrossRef

Weisz, J. R., & Kazdin, A. E. (Eds.). (2010). Evidence-based psychotherapies for children and adolescents (2nd ed.). New York: Guilford.

Weisz, J. R., McCarty, C. A., & Valeri, S. M. (2006). Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin, 132(1), 132–149.PubMedCentralPubMedCrossRef

Weisz, J. R., Weiss, B., Alicke, M. D., & Klotz, M. L. (1987). Effectiveness of psychotherapy with children and adolescents: A meta-analysis for clinicians. Journal of Consulting and Clinical Psychology, 55(4), 542–549.PubMedCrossRef

Weisz, J. R., Weiss, B., Han, S. S., Granger, D. A., & Morton, T. (1995). Effects of psychotherapy with children and adolescents revisited: A meta-analysis of treatment outcome studies. Psychological Bulletin, 117(3), 450–468.PubMedCrossRef

Wolpaw, T. M., Wolpaw, D. R., & Papp, K. K. (2003). SNAPPS: A learner-centered model for outpatient education. Academic Medicine, 78(9), 893–898.PubMedCrossRef

Yager, J. (2011). The practice of psychiatry in the 21st century: Challenges for psychiatric education. Academic Psychiatry, 35(5), 283–292.PubMedCrossRef

Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283(8), 1025–1030.PubMedCrossRef

Titel: A Model of Pediatric Psychopharmacology-Psychotherapy Treatment Integration in the Ambulatory Clinical Setting
Auteurs: Daniel F. Connor
Alok Banga
Publicatiedatum: 01-05-2014
Uitgeverij: Springer US
Gepubliceerd in: Journal of Child and Family Studies / Uitgave 4/2014
Print ISSN: 1062-1024
Elektronisch ISSN: 1573-2843
DOI: https://doi.org/10.1007/s10826-012-9613-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2014

Outpatient Psychotropic Medication Use in the US: A Comparison Based on Foster Care Status

Use of Psychotropic Medications Among Youth in Treatment Foster Care

Psychotropic Medication Management Within Residential Treatment Centers: Physician Opinions About Difficulties and Barriers

Use of Psychiatric Medications in Juvenile Detention Facilities and the Impact of State Placement Policy

Review of State Medication Policies/Guidelines Regarding Psychotropic Medications in Public Schools

Reducing Psychotropic Medications in an Intensive Residential Treatment Center